AUTL — Autolus Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $1.09bn
- $379.73m
- $1.70m
- 37
- 10
- 65
- 31
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 20-F | 20-F | 20-F | 20-F | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 211 | 153 | 310 | 382 | 240 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 30.5 | 29.7 | 26.3 | 29 | 24.5 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 249 | 197 | 347 | 426 | 275 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 51.6 | 89.7 | 52.3 | 58.4 | 95.7 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 304 | 294 | 406 | 490 | 375 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 25 | 33.6 | 28.6 | 46.4 | 44.7 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 48.7 | 84.2 | 92.2 | 192 | 264 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 255 | 210 | 313 | 299 | 111 |
Total Liabilities & Shareholders' Equity | 304 | 294 | 406 | 490 | 375 |